Skip to main content
Equibles

Assenagon Asset Management S.A.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1546007 SENNINGERBERG, N4
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 21, 2026
Position Value
$3,403,369
-$24,024,275 QoQ
Shares Held
73,175
-86.2% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 335 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. SUPN ranks #13 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 3,056,017 $103,537,855
2 LNTH
Lantheus Holdings, Inc.
 714,980 $79,319,881
3 VTRS
Viatris Inc
 4,989,006 $79,225,415
4 INDV
Indivior Pharmaceuticals, Inc.
 1,540,928 $63,224,275
5 UTHR
UNITED THERAPEUTICS Corp
 84,538 $45,805,224
6 AMRX
Amneal Pharmaceuticals, Inc.
 2,445,549 $42,332,453
7 NBIX
Neurocrine Biosciences Inc
 222,606 $37,518,015
8 ZTS
Zoetis Inc.
 389,335 $27,977,613

All Filings in SUPN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,403,369 73,175
2026-03-31 $27,427,644 530,618
2023-12-31 $1,049,190 36,254
2023-03-31 $1,988,628 54,889
2022-12-31 $5,992,916 168,010
2022-09-30 $1,428,977 42,215
2022-06-30 $1,220,857 42,215
2021-12-31 $2,023,383 69,389